A review, published in IJTLD OPEN, covers best practices for caring for people with expanded resistance to newer TB drugs.
Strains of Mycobacterium tuberculosis with resistance to the new and repurposed drugs included in the all-oral shorter TB regimens recommended by the World Health Organization for the treatment of multidrug-resistant/rifampicin-resistant TB (MDR/RR-TB) are becoming increasingly common globally. In the absence of trial data on how to care for individuals with these forms of TB, the review discusses a series of best clinical practices, generated by a group of clinical, programmatic and civil society experts, based on the published literature and on experience caring for these individuals.
Access the review here.
For more TB updates, check out the TB CAB Weekly Newsletter (Issue #21, 30 June 2025).
The newsletter is brought to you by the Global TB Community Advisory Board (TB CAB) with the support of Treatment Action Group (TAG) and EATG. Subscribe to the newsletter here.
Source : IJTLD OPEN
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.